UroGen Pharma Announces Date for ENVISION Data, New Long-Term Jelmyto Durability Data, and Reports 2024 First Quarter Financial Results and Business Highlights

View Full Size 

Download

• Full Size JPEG, 1894x553, 258.8 KB
• Small JPEG, 480x140, 53.2 KB
• Preview JPEG, 144x42, 10.7 KB
• Thumbnail JPEG, 120x35, 8.8 KB